International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer


Recommended Conferences for Neoplasms


As per available reports about 125 Conference Proceedings, 1 relevant journals , 16 Conferences , 21 National symposiums are presently dedicated exclusively to Neoplasms and about 82 articles which are hosed by OMICS International.

A neoplasm is an abnormal mass of tissue , the growth of which exceeds and is uncoordinated with that of the normal tissues, and persists in the same excessive manner after cessation of the stimulus which evoked the change." The body is made up of trillions of cells that grow, divide, and die in an orderly fashion. This process is a tightly regulated one that is controlled by the DNA machinery within the cell . When a person is growing up, the cells of the body rapidly divide, but once adulthood is reached, cells generally only divide to replace worn-out, dying cells or to repair injured cells.

Importance and Scope

Neoplasms is a generic term for a large group of diseases that can affect any part of the body. Other terms used are malignant tumors and cancer. Metastases are the major cause of death from cancer. Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012. About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008 worldwide, with 56% of the cases and 64% of the deaths in the economically developing world. Breast cancer, the most common tumour in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years. Colorectal cancer (of the colon and rectum), the most common malignant tumour if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer. Prostate cancer, today the most common tumour in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

Neoplasm types:

The different types of neoplasm include:
• Benign or non-cancerous- Benign neoplasms are non-cancerous forms of tissue proliferation such as skin moles, lipomas or uterine fibroids. These neoplasms do no not become cancerous and mainly cause problems due to their space-occupying nature.
• Pre-malignant or pre-cancerous- Precancerous neoplasms are masses that have the potential to become cancerous. The earliest form of precancer is dysplasia. The cells proliferate only in their site of origin and do not spread. However, dysplasia may become high-grade and develop intocarcinoma in situ which carries a high risk of turning into cancer
• Malignant or cancerous- These terms are used to describe neoplasms that have become cancerous, as defined by the following distinct features, Abnormal cell growth, Capacity to invade other tissues , Capacity to spread to distant organs via blood vessels or lymphatic channels (metastasis).These cancers have the capacity to take over the whole body and eventually kill the host.

Causes of Neoplasia:

The origin for many neoplasms is obscure. However, there are several theories of origin.
• Chemicals: including those that are man-made (such as aniline dyes and bladder cancer), drugs (cigarette smoke and lung cancer), and natural compounds (aflatoxins and liver cancer) which are carcinogenic.
• Oncogenic viruses: such as human papillomavirus (HPV) implicated in most squamous a href=" " > cell carcinomas of cervix and anogenital squamous papillomas, Epstein-Barr virus (EBV) implicated in African Burkitt's lymphoma, and hepatitis B virus (HBV) implicated in development of hepatocellular carcinomas.
• Radiation: including ultraviolet light that induces pyrimidine dimers in DNA and promotes skin cancers . Ionizing radiation (such as gamma radiation) induces mutations in DNA and promotes malignancies such as leukemia, thyroid, lung, colon, and breast cancers.
• Hereditary causes: Chromosomes which have absent or defective anti-oncogenes that control growth (retinoblastoma results from defective chromosome 13)
• Obscure defects: Racial predilections (American women have breast cancer more often than Japanese women; Japanese men have stomach cancer far more often than American men).
• Age: Older persons have a greater propensity to develop neoplasms from lack of effective control mechanisms.

Diagnosis of Neoplasia:

-History and Physical Examination: What the health care worker learns from talking to the patient and through direct examination may give clues to the presence of a neoplasm. Signs and symptoms such as weight loss , fatigue, and pain may be present. A mass may be palpable or visible.
Radiographic Techniques: The use of plain films (x-rays), computed tomography (CT), magnetic resonance imaging (MRI), mammography, and ultrasonography (US) may be very helpful to detect the presence and location of mass lesions. The findings from these methods may aid in staging and determination of therapy.
-Laboratory Analyses: General findings such as anemia, enzyme abnormalities (such as an increased alkaline phosphatase), and hematuria or positive stool occult blood are helpful to suggest further workup. Tumor markers in serum such as carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), or human chorionic gonadotropin (HCG) can be performed. Unfortunately, they are not all that specific or sensitive, particularly when applied as screening tests to a general population. More specific testing, such as measurement of prostate specific antigen (PSA) levels, may help to determine the presence of specific neoplasms, but such tests are not perfect screening tools in a general population.
-Genetic Testing: Genetic markers include chromosomal alterations (translocations, deletions, duplication, etc.); specific gene defects; single nucleotide polymorphisms, and gene rearrangements. Detection of specific genes (such as BRCA-1 for breast cancer) may suggest an increased risk for some malignancies. Cytology: Methods that sample cells can be simple and cost-effective and minimally invasive. A good example is the Pap smear for diagnosis of cervical dysplasias and neoplasms. a href=" " > cells exfoliated into body fluids may also be examined. Fine needle aspiration (FNA) can be used to sample a variety of mass lesions.
-Tissue Biopsy and Surgery: Methods that sample small pieces of tissue (biopsy) from a particular site, often via endoscopic techniques (such as colonoscopy, upper endoscopy, or bronchoscopy) can often yield a specific diagnosis of malignancy. At surgery, portions of an organ or tissue can be sampled, or the diseased tissue(s) removed and examined in surgical pathology to determine the stage and grade of the neoplasm.
-Autopsy: Sometimes neoplasms are not detected or completely diagnosed during life. The autopsy serves as a means of quality assurance for clinical diagnostic methods, as a way of confirming diagnoses helpful in establishing risks for family members, as a means for gathering statistics for decision making about how to approach diagnosis and treatment of neoplasms, and to provide material for future research.

Market Value
Globally, the burden of new cancer cases in the year 2000 was estimated to be around 10.1 million, developing world contributing to 53% of this load. The burden of cancer is increasing worldwide despite advances in cancer diagnosis and treatment. However, the worldwide cancer statistics depict that14.1 million adults in the world were diagnosed with cancer and 8.2 million deaths occurred in 2012.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

List of Best International Conferences

1.  3rd Hematology & Blood Disorders Conference

November 02-04, 2015, Atlanta, USA

2.  Pediatric Emergency Medicine Conference

March 29-31, 2016, Atlanta, USA

3.  5th Pathology Conference

May 09-11, 2016, Chicago, USA

4.  Pancreatic Disorders And Treatment Conference

May 12-14, 2016, Chicago, USA

5.  6th Cell & Stem Cell Research Congress

February 29-March 02, 2016, Philadelphia, USA

6.  Musculoskeletal Regeneration Conference

May 05-06, 2016, Chicago, USA

7.  5th Tissue Science And Regenerative Medicine Conference

September 12-14, 2016, Berlin, Germany

8.  6th Cancer Therapy Congress

December 01-03, 2016 Baltimore, USA

9.  7th Cancer Therapy summit 

October 05-07, 2015 Dubai, UAE

10.   2nd Clinical Case Reports 

April 18-20, 2016 Dubai, UAE

11.   3rd Medical Case Reports 

May 12-14, 2016 San Francisco, USA

12.   Cancer Immunology and Immunotherapy Conference

July 28-30, 2016 Melbourne, Australia

13.   Thyroid Cancer and Treatment Conference

Aug 1-3, 2016 Toronto, Canada

14.   Pediatric Oncology Conference

August 04-06, 2016 Toronto, Canada

15.   Pediatric Oncology Conference

August 04-06, 2016 Toronto, Canada

16.   Oral, Mouth and Throat Cancer Conference

August 18-20, 2016 Portland, USA

17.   Oncology Nursing and Cancer Care Conference

Sept 19-21, 2016 Las Vegas, USA

18.   2nd Breast Cancer Conference

September 19-21, 2016 Phoenix, USA

19.   6th International Conference on Myeloproliferative Neoplasms

20.   European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes CME

21.   ESH International Conference on Myeloproliferative Neoplasms

Related Societies/ Associations

  • The American Brain Tumor Association
  • American Association for Cancer Research
  • The European Association for Cancer Research
  • International Association of Cancer Registries
  • American society of clinical Oncology
  • Australian Cancer Research Foundation (ACRF)
  • Armenian Association of Hematology and Oncology
  • Asian Society for Neuro-Oncology
  • Association for International Cancer Research
  • Association for Multiple Endocrine Neoplasia Disorders
  • Association for the Study of Lung Cancer
  • Association of Cancer Online Resources ACOR
  • Association of Cancer Physicians
  • Association of Community Cancer Centers
  • Association of European Cancer Leagues
  • Association of Gynecologic Oncologists of India
  • Association of Oncology Social Work
  • Association of Parents of Children with Cancer
  • Brain Tumor Foundation of Canada
  • Children’s Brain Tumor Foundation

Related Companies

  • Roche
  • Novartis
  • Celgene
  • Johnson & Johnson
  • Bristol-Myers Squibb
  • Lilly
  • Takeda
  • AstraZeneca
  • Merck & Co.
  • Amgen
  • Pfizer
  • Astellas
  • Bayer
  • Otsuka
  • Sanofi
  • Merck KGaA
  • Eisai
  • AbbVie
  • Pharmacyclics
  • Incyte
  • ProPath
  • Biogen Idec
  • gsk

This page will be updated regularly.

This page was last updated on February 23, 2024

Conference Series Destinations